Biotech investing has become an increasingly popular in recent years. Whether you’re new to biotech stocks or you’ve been around the block, with the recent stock market drops caused by COVID-19, now could be a good time to place your bets.
The stock market had its largest point drop in recent history on March 9, 2020. Shortly thereafter, on March 12 and March 16, there were two more record-setting point drops. Even though the market has recovered somewhat following the $2.2 trillion stimulus bill, market prices remain attractive across many sectors.
Furthermore, stem cell companies are receiving startling support for use of living therapeutics against COVID-19 induced respiratory complications, such as ARDS. The Australian company, Mesoblast, is now enrolling for a 300 person trial and the American company, Athersys, is enrolling for an even larger 400 person trial.
Under these conditions, one of the most intriguing niches within biotech investing is stem cell stocks. [Read more…]